alpha-methylacyl-CoA racemase deficiency

A rare disorder caused by mutation in the AMACR gene. Racemization is the prerequisite to beta-oxidation for branched chain fatty acids and bile acids. It is characterized by neurological abnormalities that appear in adulthood and include cognitive decline, seizures, and sensorimotor neuropathy. AMACR deficiency rarely presents as liver disease in infancy.

Also known as: AMACR, AMACR deficiency, alpha-methylacyl-CoA racemase deficiency, AMACRD.

Category: General

Looking into alpha-methylacyl-CoA racemase deficiency? See the lab tests healthcare providers may use to investigate alpha-methylacyl-CoA racemase deficiency, and learn what each one measures.
Explore tests for alpha-methylacyl-CoA racemase deficiency
Symptoms

Symptoms associated with alpha-methylacyl-CoA racemase deficiency

The following symptoms have been associated with alpha-methylacyl-CoA racemase deficiency in medical literature. Not everyone experiences the same symptoms.

Tests

Tests used to investigate alpha-methylacyl-CoA racemase deficiency

Healthcare providers may order these tests when evaluating alpha-methylacyl-CoA racemase deficiency. Test selection is a clinical decision made by a qualified professional.

CBC with Differential

Measures red blood cells, white blood cells, and platelets to help evaluate overall health and detect disorder...

Sample: Blood

Comprehensive Metabolic Panel (CMP)

Measures 14 substances in the blood to assess kidney and liver function, electrolyte balance, and blood sugar ...

Sample: Blood

Urinalysis

Examines urine content to help detect urinary tract infections, kidney disease, and diabetes....

Sample: Urine

Related conditions

Conditions with overlapping symptoms

These conditions share symptoms with alpha-methylacyl-CoA racemase deficiency, which is why a clinical evaluation is important.

FAQ

Frequently Asked Questions

What is alpha-methylacyl-CoA racemase deficiency?

alpha-methylacyl-CoA racemase deficiency is a health condition described in medical literature. A rare disorder caused by mutation in the AMACR gene. Racemization is the prerequisite to beta-oxidation for branched chain fatty acids and bile acids. It is characterized by neurological abnormalities that appear in adulthood and include cognitive decline, seizures, and sensorimotor neuropathy. AMACR deficiency rarely presents as liver disease in infancy.

What are the symptoms of alpha-methylacyl-CoA racemase deficiency?

alpha-methylacyl-CoA racemase deficiency is associated with 8 symptoms in the medical literature we index, including Depression, Focal-onset seizure, Hemiparesis, Intention tremor, Migraine, Seizure. Symptoms vary widely between individuals.

How is alpha-methylacyl-CoA racemase deficiency diagnosed or investigated?

A healthcare provider may use a combination of medical history, physical examination, and tests. Common tests associated with alpha-methylacyl-CoA racemase deficiency include CBC with Differential, Comprehensive Metabolic Panel (CMP), Urinalysis. This information is educational, not a diagnosis.

Is SymptomDatabase.com diagnosing me?

No. SymptomDatabase.com does not provide diagnosis. If you are concerned you may have alpha-methylacyl-CoA racemase deficiency, please discuss your symptoms with a qualified healthcare provider.

Educational content only: The information on Symptom Database.com is for educational purposes and is not medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider. Read our full disclaimer.